Metastatic renal cell carcinoma: response to treatment with human recombinant erythropoietin

Ann Intern Med. 1995 May 1;122(9):676-7. doi: 10.7326/0003-4819-122-9-199505010-00005.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / secondary*
  • Erythropoietin / therapeutic use*
  • Humans
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology
  • Male
  • Neoplasm Invasiveness
  • Recombinant Proteins / therapeutic use
  • Treatment Outcome

Substances

  • Recombinant Proteins
  • Erythropoietin